Segui
Silvia Rivara
Silvia Rivara
Dipartimento di Scienze degli Alimenti e del Farmaco
Email verificata su unipr.it - Home page
Titolo
Citata da
Citata da
Anno
Cyclohexylcarbamic acid 3 ‘-or 4 ‘-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure− activity relationships, and…
M Mor, S Rivara, A Lodola, PV Plazzi, G Tarzia, A Duranti, A Tontini, ...
Journal of medicinal chemistry 47 (21), 4998-5008, 2004
3282004
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus
JK Makara, M Mor, D Fegley, SI Szab, S Kathuria, G Astarita, A Duranti, ...
Nature neuroscience 8 (9), 1139-1141, 2005
2612005
Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation
C Solorzano, C Zhu, N Battista, G Astarita, A Lodola, S Rivara, M Mor, ...
Proceedings of the National Academy of Sciences 106 (49), 20966-20971, 2009
2582009
Design, synthesis, and structure− activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors
G Tarzia, A Duranti, A Tontini, G Piersanti, M Mor, S Rivara, PV Plazzi, ...
Journal of medicinal chemistry 46 (12), 2352-2360, 2003
2092003
MT1 and MT2 Melatonin Receptors: Ligands, Models, Oligomers, and Therapeutic Potential
DP Zlotos, R Jockers, E Cecon, S Rivara, PA Witt-Enderby
Journal of medicinal chemistry 57 (8), 3161-3185, 2014
1972014
Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases
S Rivara, FM Milazzo, G Giannini
Future medicinal chemistry 8 (6), 647-680, 2016
1722016
Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand
R Ochoa-Sanchez, S Comai, B Lacoste, FR Bambico, ...
Journal of Neuroscience 31 (50), 18439-18452, 2011
1392011
Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice
J LoVerme, A Duranti, A Tontini, G Spadoni, M Mor, S Rivara, N Stella, ...
Bioorganic & medicinal chemistry letters 19 (3), 639-643, 2009
1272009
URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices
AR King, A Duranti, A Tontini, S Rivara, A Rosengarth, JR Clapper, ...
Chemistry & biology 14 (12), 1357-1365, 2007
1262007
2-[N-Acylamino(C1−C3)alkyl]indoles as MT1 Melatonin Receptor Partial Agonists, Antagonists, and Putative Inverse Agonists
G Spadoni, C Balsamini, A Bedini, G Diamantini, B Di Giacomo, A Tontini, ...
Journal of medicinal chemistry 41 (19), 3624-3634, 1998
1221998
Pharmacological characterization of hydrolysis-resistant analogs of oleoylethanolamide with potent anorexiant properties
G Astarita, B Di Giacomo, S Gaetani, F Oveisi, TR Compton, S Rivara, ...
Journal of Pharmacology and Experimental Therapeutics 318 (2), 563-570, 2006
1082006
Pharmacological characterization of hydrolysis-resistant analogs of oleoylethanolamide with potent anorexiant properties
G Astarita, B Di Giacomo, S Gaetani, F Oveisi, TR Compton, S Rivara, ...
Journal of Pharmacology and Experimental Therapeutics 318 (2), 563-570, 2006
1082006
Melatonin receptor ligands: Synthesis of new melatonin derivatives and comprehensive comparative molecular field analysis (CoMFA) study
M Mor, S Rivara, C Silva, F Bordi, PV Plazzi, G Spadoni, G Diamantini, ...
Journal of medicinal chemistry 41 (20), 3831-3844, 1998
991998
N-(Substituted-anilinoethyl)amides: Design, Synthesis, and Pharmacological Characterization of a New Class of Melatonin Receptor Ligands
S Rivara, A Lodola, M Mor, A Bedini, G Spadoni, V Lucini, M Pannacci, ...
Journal of medicinal chemistry 50 (26), 6618-6626, 2007
982007
Analysis of Structure−Activity Relationships for MT2 Selective Antagonists by Melatonin MT1 and MT2 Receptor Models
S Rivara, S Lorenzi, M Mor, PV Plazzi, G Spadoni, A Bedini, G Tarzia
Journal of medicinal chemistry 48 (12), 4049-4060, 2005
912005
Conformationally restrained melatonin analogues: synthesis, binding affinity for the melatonin receptor, evaluation of the biological activity, and molecular modeling study
G Spadoni, C Balsamini, G Diamantini, B Di Giacomo, G Tarzia, M Mor, ...
Journal of medicinal chemistry 40 (13), 1990-2002, 1997
901997
Anxiolytic effects of the melatonin MT2 receptor partial agonist UCM765: Comparison with melatonin and diazepam
R Ochoa-Sanchez, Q Rainer, S Comai, G Spadoni, A Bedini, S Rivara, ...
Progress in neuro-psychopharmacology and biological psychiatry 39 (2), 318-325, 2012
872012
Melatonin receptor agonists: new options for insomnia and depression treatment
G Spadoni, A Bedini, S Rivara, M Mor
CNS neuroscience & therapeutics 17 (6), 733-741, 2011
812011
Irreversible inhibition of epidermal growth factor receptor activity by 3-aminopropanamides
C Carmi, E Galvani, F Vacondio, S Rivara, A Lodola, S Russo, S Aiello, ...
Journal of medicinal chemistry 55 (5), 2251-2264, 2012
772012
Melatonin receptor agonists: SAR and applications to the treatment of sleep-wake disorders
S Rivara, M Mor, A Bedini, G Spadoni, G Tarzia
Current topics in medicinal chemistry 8 (11), 954-968, 2008
772008
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20